There may be significant gastrointestinal side effects, such as diarrhea; however, most patients are able to tol- erate low doses of colchicine. If diarrhea does develop, it is important to watch for hypovolemia and hypokalemiaIntra-articular steroids are useful for monoar- ticular attack once ...
FARXIGA® (dapagliflozin), a medication for people with chronic kidney disease (CKD), heart failure with symptoms, and type 2 diabetes.
heart failure risk is not limited to individuals with Type 2 diabetes. People with Type 1 diabetes are also at increased risk. For instance, in a recent prospective case–control study of 33,402 individuals with Type 1 diabetes and 166,228 matched controls, the hazard ratio (HR) for hospita...
Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal fluid accumulation; the ventricles can be involved together or separately. Diagnosis is in...
Heart failure (HF) is classically defined as a “clinical syndrome caused by the inability of the heart to supply blood to the tissues commensurate to the metabolic needs of that tissue” [1,2]. From: Heart Failure in the Child and Young Adult, 2018 ...
Melphalan Fludarabine Heart failure Introduction Advances in chemotherapy and radiotherapy have had the greatest impact on cancer survival, but their combined side effects have led patients to deal with serious organic complications as a result of their treatment. In attempting to treat the cancer, many...
Previous findings have indicated the potential benefits of the Chinese traditional medicine Qiliqiangxin (QLQX) in heart failure. Here we performed a double-blind, randomized controlled trial to evaluate the efficacy and safety of QLQX in patients with h
The most common side effects of Multaq are diarrhea, nausea, abdominal pain, vomiting, and weakness. Multaq contains a black-box warning — the strictest allowed by law — due to the potential increased risk of death in people with severe heart failure. In 2011, the FDA notified healthcare...
The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure, Boehringer Ingelheim and Eli Lill...
Lexicon Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved INPEFA™, a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults w